Abiopharma

🔍 Seymour June Ann (Executive)

Company: Cartesian Therapeutics, Inc. (RNAC)

Report Date: 2025-10-27

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Employee Stock Option (right to buy) at $8.85 per share (Derivative)
  Date: 2025-10-27 | Code: A | Expires: 2035-10-27 | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This option vests as to 25% on October 27, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on October 27, 2029.